X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
aged (16) 16
female (16) 16
index medicus (16) 16
middle aged (15) 15
osteoporosis (15) 15
endocrinology & metabolism (13) 13
bone density conservation agents - therapeutic use (11) 11
osteoporosis, postmenopausal - drug therapy (11) 11
internal medicine (10) 10
rheumatology (10) 10
surgery (10) 10
endocrinology (9) 9
medicine & public health (9) 9
orthopedics (9) 9
postmenopausal women (9) 9
bone density conservation agents - administration & dosage (8) 8
fractures (8) 8
gynecology (8) 8
research (8) 8
women (8) 8
adherence (7) 7
compliance (7) 7
drug therapy (7) 7
health policy (7) 7
medication adherence (7) 7
public health, environmental and occupational health (7) 7
treatment outcome (7) 7
alendronate (6) 6
denosumab (6) 6
patient preference (6) 6
persistence (6) 6
risk factors (6) 6
united states (6) 6
administration, oral (5) 5
alendronate - administration & dosage (5) 5
antibodies, monoclonal, humanized (5) 5
beliefs (5) 5
bone density - drug effects (5) 5
bone density conservation agents - adverse effects (5) 5
health aspects (5) 5
medication (5) 5
patient compliance (5) 5
risk (5) 5
aged, 80 and over (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal - therapeutic use (4) 4
care and treatment (4) 4
drug administration schedule (4) 4
epidemiologic methods (4) 4
fractures, bone - etiology (4) 4
impact (4) 4
injections, subcutaneous (4) 4
monthly ibandronate (4) 4
osteoporosis - drug therapy (4) 4
osteoporosis, postmenopausal - complications (4) 4
osteoporosis, postmenopausal - physiopathology (4) 4
questionnaire (4) 4
retrospective studies (4) 4
therapy (4) 4
alendronate - adverse effects (3) 3
alendronate - therapeutic use (3) 3
antibodies, monoclonal - adverse effects (3) 3
bisphosphonate therapy (3) 3
bisphosphonates (3) 3
bone density conservation agents - economics (3) 3
bone mineral density (3) 3
breast reconstruction (3) 3
chemotherapy (3) 3
clinical trials (3) 3
complications (3) 3
complications and side effects (3) 3
diphosphonates - therapeutic use (3) 3
dosage and administration (3) 3
drug-therapy (3) 3
fracture rates (3) 3
health care costs (3) 3
low bone mass (3) 3
male (3) 3
management (3) 3
men (3) 3
original (3) 3
osteoporosis, postmenopausal - psychology (3) 3
patient outcomes (3) 3
postmenopausal (3) 3
postmenopausal osteoporosis (3) 3
preferences (3) 3
prevention (3) 3
psychometrics (3) 3
quality of life (3) 3
radiation (3) 3
reconstruction (3) 3
time factors (3) 3
vertebral fractures (3) 3
adult (2) 2
analysis (2) 2
bone (2) 2
bone density (2) 2
breast (2) 2
breast cancer (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Osteoporosis International, ISSN 0937-941X, 5/2010, Volume 21, Issue 5, pp. 837 - 846
Journal Article
Osteoporosis International, ISSN 0937-941X, 1/2012, Volume 23, Issue 1, pp. 317 - 326
The final analysis of this 2-year, randomized, crossover study showed that postmenopausal women with osteoporosis were more adherent, compliant, and persistent... 
Adherence | Persistence | Medicine & Public Health | Alendronate | Compliance | Orthopedics | Gynecology | Rheumatology | Denosumab | Endocrinology | MEDICATION | FRACTURE RATES | OSTEOPOROSIS | LOW BONE MASS | THERAPY | INJECTION | PATIENT PREFERENCE | ENDOCRINOLOGY & METABOLISM | BELIEFS | QUESTIONNAIRE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Alendronate - therapeutic use | Antibodies, Monoclonal, Humanized | Injections, Subcutaneous | Female | Bone Density Conservation Agents - adverse effects | Drug Administration Schedule | Administration, Oral | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Patient Preference | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Cross-Over Studies | Alendronate - adverse effects | Bone Density - drug effects | Medication Adherence | RANK Ligand - antagonists & inhibitors | Antibodies, Monoclonal - administration & dosage | Osteoporosis, Postmenopausal - physiopathology | Aged | Alendronate - administration & dosage | Patient compliance | Research | Clinical trials | Comparative studies | Drug therapy | Womens health | Alendronic acid | Osteoporosis | Bone mineral density | Tablets | Bisphosphonates | Post-menopause | Original
Journal Article
Osteoporosis International, ISSN 0937-941X, 2012, Volume 23, Issue 4, pp. 1361 - 1369
Summary In the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) study, women with incident clinical fractures reported... 
Incident clinical fracture | Health-related quality of life | Osteoporosis | Medicine & Public Health | Orthopedics | Gynecology | OPAQ-SV | Rheumatology | Endocrinology | OPAQ-SV. Osteoporosis | VERTEBRAL FRACTURES | PREVALENT | ENDOCRINOLOGY & METABOLISM | OSTEOPOROSIS ASSESSMENT QUESTIONNAIRE | OUTCOMES | POSTMENOPAUSAL WOMEN | Bone Density - physiology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Spinal Fractures - rehabilitation | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | Osteoporosis, Postmenopausal - rehabilitation | Osteoporotic Fractures - rehabilitation | Time Factors | Back Pain - rehabilitation | Aged, 80 and over | Female | Lumbar Vertebrae - physiopathology | Back Pain - etiology | Spinal Fractures - psychology | Osteoporotic Fractures - prevention & control | Bone Density Conservation Agents - therapeutic use | Osteoporotic Fractures - psychology | Psychometrics | Denosumab | Osteoporosis, Postmenopausal - drug therapy | Bone Density - drug effects | RANK Ligand - antagonists & inhibitors | Hip Joint - physiopathology | Spinal Fractures - complications | Quality of Life | Osteoporosis, Postmenopausal - physiopathology | Aged | Osteoporosis, Postmenopausal - psychology | Complications and side effects | Fractures | Research | Health aspects | Risk factors | Quality of life | Vertebrae | Statistical analysis | Calcium | Spine (lumbar) | Clinical trials | Emotions | Hip | Pain | Vitamin D | Bone mineral density
Journal Article
Osteoporosis International, ISSN 0937-941X, 6/2011, Volume 22, Issue 6, pp. 1725 - 1735
In this study, 250 women with osteoporosis were randomized to 12 months with subcutaneous denosumab 60 mg every 6 months or oral alendronate 70 mg once weekly,... 
Adherence | Persistence | Medicine & Public Health | Alendronate | Compliance | Gynecology | Orthopedics | Rheumatology | Denosumab | Endocrinology | TURNOVER | FRACTURE RATES | MONTHLY IBANDRONATE | LOW BONE MASS | DENSITY | TRIAL | THERAPY | PATIENT PREFERENCE | ENDOCRINOLOGY & METABOLISM | OSTEOPOROTIC WOMEN | BELIEFS | Medication Adherence - statistics & numerical data | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Alendronate - therapeutic use | Antibodies, Monoclonal, Humanized | Patient Satisfaction - statistics & numerical data | Injections, Subcutaneous | Female | Bone Density Conservation Agents - adverse effects | Administration, Oral | Patient Preference - statistics & numerical data | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | British Columbia | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Alendronate - adverse effects | Bone Density - drug effects | Antibodies, Monoclonal - administration & dosage | Epidemiologic Methods | Osteoporosis, Postmenopausal - physiopathology | Aged | Osteoporosis, Postmenopausal - psychology | Alendronate - administration & dosage | Postmenopausal women | Dosage and administration | Management | Behavior | Drug therapy | Patient compliance | Women | Osteoporosis | Side effects | Preferences
Journal Article
Journal Article
Value in Health, ISSN 1098-3015, 2011, Volume 14, Issue 8, pp. 1109 - 1116
Journal Article
Osteoporosis International, ISSN 0937-941X, 12/2013, Volume 24, Issue 12, pp. 3001 - 3010
Journal Article
Value in Health, ISSN 1098-3015, 10/2018, Volume 21, pp. S252 - S252
Journal Article
Annals of Surgery, ISSN 0003-4932, 03/2018, Volume 267, Issue 3, pp. e58 - e59
Journal Article
Value in Health, ISSN 1098-3015, 2014, Volume 17, Issue 7, pp. A649 - A650
Journal Article
Value in Health, ISSN 1098-3015, 11/2014, Volume 17, Issue 7, pp. A649 - A650
Journal Article
Value in Health, ISSN 1098-3015, 2015, Volume 18, Issue 3, pp. A50 - A51
Journal Article